Skip to main content

previous disabled Page of 3
and
  1. No Access

    Article

    Application of Photofrin II as a specific radiosensitising agent in patients with bladder cancer—a report of two cases

    Background: the effect of ionizing radiation on tumour tissues can be optimised by adding radiosensitising agents to enhance tumour inactivation. Photofrin II has been approved as a photosensitising agent for ...

    M. Schaffer, P. M. Schaffer, M. Vogesser in Photochemical & Photobiological Sciences (2002)

  2. Article

    Open Access

    High efficiency of benzoporphyrin derivative in the photodynamic therapy of pigmented malignant melanoma

    Benzoporphyrin derivative monoacid ring A (verteporfin, BPD-MA) when intravenously injected (5.5 μmol kg–1) to C57/BL6 mice bearing a subcutaneously transplanted B1 melanoma gave a maximal accumulation in the tum...

    A Busetti, M Soncin, G Jori, M A J Rodgers in British Journal of Cancer (1999)

  3. No Access

    Article

    Laser-induced fluorescence studies of the biodistribution of carotenoporphyrins in mice

    The biodistribution of two recently developed tumour markers, trimethylated (CP(Me)3) and trimethoxylated (CP(OMe)3) carotenoporphyrin, was investigated by means of laser-induced fluorescence (LIF) after i.v. ...

    H Nilsson, J Johansson, K Svanberg, S Svanberg, G Jori in British Journal of Cancer (1997)

  4. No Access

    Article

    Tumour-localising and -photosensitising properties of a novel zinc(II) octadecylphthalocyanine

    1,4,8,11,15,18,22,25-Octadecylphthalocyaninato zinc(II), ZnODPc, incorporated into a Cremophor emulsion, was assayed for its pharmacokinetic and phototherapeutic properties in Balb/c mice bearing an intramuscu...

    C Ometto, C Fabris, C Milanesi, G Jori, MJ Cook, DA Russell in British Journal of Cancer (1996)

  5. No Access

    Chapter and Conference Paper

    Photodynamic Therapy of B16 Pigmented Melanoma with Si(IV)Naphthalocyanine Photoactivated by Diode Laser

    Melanotic malignant melanoma represents a major cause of death among skin neoplasias and its incidence is steadily increasing in Western world probably owing to changes in lifestyle which favour brief but inte...

    M. Schaffer, G. Jori, R. Biolo, P. M. Schaffer in Laser in der Medizin / Laser in Medicine (1996)

  6. No Access

    Article

    Effect of axial ligation and delivery system on the tumour-localising and -photosensitising properties of Ge(IV)-octabutoxy-phthalocyanines

    Four Ge(IV)-octabutoxy-phthalocyanines (GePcs) bearing two alkyl-type axial ligands were assayed for their pharmacokinetic properties and phototherapeutic efficiency in Balb/c mice bearing an intramuscularly t...

    M Soncin, L Polo, E Reddi, G Jori, ME Kenney, G Cheng in British Journal of Cancer (1995)

  7. No Access

    Article

    Photodynamic therapy of experimental tumours with Zn(II)-phthalocyanine and pulsed laser irradiation

    The effectiveness of a pulsed dye laser (673 nm) for photodynamic therapy (PDT) of tumours in the presence of Zn(II)-phthalocyanine (ZnPc) was evaluated using Lewis lung carcinoma-bearing mice. The tumours wer...

    M. Shopova, N. Stoichkov, A. Milev, M. Peev, K. Georgiev in Lasers in Medical Science (1995)

  8. No Access

    Article

    Laser-induced fluorescence in malignant and normal tissue in mice injected with two different carotenoporphyrins

    Laser-induced fluorescence (LIF) was used to characterise the localisation of an intravenously administered trimethylated carotenoporphyrin [CP(Me)3] and a trimethoxylated carotenoporphyrin [CP(OMe)3] in an in...

    H Nilsson, J Johansson, K Svanberg, S Svanberg, G Jori in British Journal of Cancer (1994)

  9. No Access

    Article

    In vivo fluorescence and photodynamic activity of zinc phthalocyanine administered in liposomes

    Zinc(II) phthalocyanine, a hydrophobic photosensitiser, was incorporated in unilamellar liposomes and studied in vivo for fluorescence kinetics and photodynamic activity. An observation chamber mounted in a do...

    HLLM van Leengoed, V Cuomo, AAC Versteeg, N van der Veen in British Journal of Cancer (1994)

  10. No Access

    Article

    CGP 55398, a liposomal Ge(IV) phthalocyanine bearing two axially ligated cholesterol moieties: a new potential agent for photodynamic therapy of tumours

    Ge(IV) phthalocyanine (GePc) with two axially ligated cholesterol moieties was prepared by chemical synthesis and incorporated in a monomeric state into small unilamellar liposomes (CGP 55398). Upon photoexcit...

    A Segalla, C Milanesi, G Jori, H-G Capraro, U Isele in British Journal of Cancer (1994)

  11. No Access

    Article

    Carotenoporphyrins as selective photodiagnostic agents for tumours

    The covalent binding of a carotene moiety to one phenyl ring and meso-tetraphenyl-substituted porphyrins (see Figure 1) efficiently quenches the photosensitising activity of the porphyrin while a relatively la...

    E Reddi, A Segalla, G Jori, PK Kerrigan, PA Liddell, AL Moore in British Journal of Cancer (1994)

  12. No Access

    Article

    Tumour-localising and -photosensitizing properties of liposome-delivered Ge(IV)-octabutoxy-phthalocyanine

    V Cuomo, G Jori, B Rihter, ME Kenney, MAJ Rodgers in British Journal of Cancer (1991)

  13. No Access

    Chapter

    A Comparison of Laser and Arc-Lamp Spectroscopic Systems for In-Vivo Pharmacokinetic Measurements of Photosensitizers Used in Photodynamic Therapy

    The treatment of neoplastic tissue using photodynamic therapy is currently undergoing a worldwide concerted research effort, enabling human treatment of such tissue using the drug hematoporphyrin derivative (H...

    D. A. Russell, P. Nadeau, R. H. Pottier in Laser Systems for Photobiology and Photome… (1991)

  14. No Access

    Chapter

    Zinc(II)-Phthalocyanine as a Second-Generation Photosensitizing Agent in Tumour Phototherapy

    The use of phthalocyanines as phototherapeutic agents for tumours was first proposed in 1985 (Ben-Hur and Rosenthal, 2985). A variety of cellular and animal studies, (for a review see Spikes, 1986;Tralau et al...

    G. Jori, R. Biolo, C. Milanesi, E. Reddi, G. Valduga in Photobiology (1991)

  15. No Access

    Article

    Liposome- or LDL-administered Zn(II)-phthalocyanine as a photodynamic agent for tumours III. Effect of cholesterol on pharmacokinetic and phototherapeutic properties

    The pharmacokinetic behaviour of Zn-phthalocyanine (Zn-Pc) has been studied in mice bearing a transplanted MS-2 fibrosarcoma using liposomes of dipalmitoyl-phosphatidylcholine containing 15% moles of cholester...

    E. Reddi, S. Cernuschi, R. Biolo, G. Jori in Lasers in Medical Science (1990)

  16. No Access

    Article

    Liposome-delivered Si(IV)-naphthalocyanine as a photodynamic sensitiser for experimental tumours: pharmacokinetic and phototherapeutic studies

    The pharmacokinetic behaviour and phototherapeutic effectiveness of bis(di-isobutyloctadecylsil-oxy)-2,3-naphthalocyanatosilicon (iso-BOSiNc) incorporated into dipalmitoyl-phosphatidylcholine (DPPC) liposomes ...

    V Cuomo, G Jori, B Rihter, ME Kenney, MAJ Rodgers in British Journal of Cancer (1990)

  17. No Access

    Article

    Zn(II)-phthalocyanine as a photodynamic agent for tumours. II. Studies on the mechanism of photosensitised tumour necrosis

    The mechanism of tumour necrosis photosensitised by liposome-delivered Zn(II) phthalocyanine (Zn-Pc) has been studied in mice bearing a transplanted MS-2 fibrosarcoma. Ultrastructural analyses of tumour specim...

    C Milanesi, C Zhou, R Biolo, G Jori in British Journal of Cancer (1990)

  18. No Access

    Article

    Liposome- or LDL-administered Zn (II)-phthalocyanine as a photodynamic agent for tumours. I. Pharmacokinetic properties and phototherapeutic efficiency

    The pharmacokinetics of Zn-phthalocyanine (Zn-Pc) in mice bearing a transplanted MS-2 fibrosarcoma has been studied using dipalmitoyl-phosphatidylcholine (DPPC) liposomes and low density lipoproteins (LDL) as ...

    E Reddi, C Zhou, R Biolo, E Menegaldo, G Jori in British Journal of Cancer (1990)

  19. Article

    TIN-PROTOPORPHYRIN (Sn-pP) EFFECT ON HYPER- BILIRUBINEMIA DUE TO CRIGLER-NAJJAR DISEASE (CND) TYPE 1

    CND is a rare disorder characterized by severe unconjugated hyperbilirubinemia appearing in the first days of life and persisting throughout life. We tried to control the hyperbilirubinemia in an infant with C...

    F F Rubaltelli, P Guerrini, E Reddi, G Jori in Pediatric Research (1989)

  20. No Access

    Article

    Accumulation of zinc-phthalocyanine (Zn-Pc) in the aorta of atherosclerotic rabbits

    Phthalocyanines are structural analogs of porphyrins and are characterized by a closely similar mechanism of transport in the bloodstream. We evaluated the accumulation of liposomebound Zn(II)-phthalocyanine (...

    A. Visonà, V. Cuomo, G. Zanetti, L. Lusiani, A. Pagnan in Lasers in Medical Science (1989)

previous disabled Page of 3